Apollon Papadimitriou
Algemeen Directeur bij iOmx Therapeutics AG
Oorsprong van het eerstegraads netwerk van Apollon Papadimitriou
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Julius-Maximilians-Universität Würzburg
16
| College/University | Other Consumer Services | 16 |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.
11
| Holding Company | Biotechnology | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Apollon Papadimitriou via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| FALKENSTEIN NEBENWERTE AG | Investment Trusts/Mutual Funds | Founder | |
| PATRYS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Investment Committee Member | |
| MORPHOSYS AG | Biotechnology | Chairman Corporate Officer/Principal | |
| SPARTA AG | Investment Managers | Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hypothekenbank Centralboden AG
 Hypothekenbank Centralboden AG Finance/Rental/LeasingFinance Hypothekenbank Centralboden AG provides banking services. The private company is based in Frankfurt, Germany. and has subsidiaries in Germany. | Finance/Rental/Leasing | Director of Finance/CFO | |
| University of Bristol | College/University | Doctorate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Chairman Director/Board Member | |
| PRIVATE ASSETS AG | Investment Managers | Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree | |
| University of Regensburg | College/University | Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Osnabrück | College/University | Graduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
MIG Verwaltungs AG
 MIG Verwaltungs AG Investment ManagersFinance MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved. | Investment Managers | Private Equity Investor | |
AMSilk GmbH
 AMSilk GmbH TextilesProcess Industries AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany. | Textiles | Director/Board Member | |
KPMG AG Wirtschaftsprüfungsgesellschaft
 KPMG AG Wirtschaftsprüfungsgesellschaft Miscellaneous Commercial ServicesCommercial Services KPMG AG Wirtschaftsprüfungsgesellschaft engages in the provision of auditing services. It also offers tax, consulting, deal advisory, and financial services. The firm focuses on various sectors such as automotive, pharmaceutical, energy, financial services, media, healthcare, industrial manufacturing, and telecommunications sectors. The company is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
SPARTA Invest AG
 SPARTA Invest AG Financial ConglomeratesFinance SPARTA Invest AG engages in the acquisition, management, and disposal of participating interests in corporations and partnerships as well as listed stock corporations. Its business activities also include the management of its own assets, financial transactions, and transactions in financial instruments. The company was founded on May 25, 2004 and is headquartered in Heidelberg, Germany. | Financial Conglomerates | Chairman | |
| Patrys GmbH | Chief Executive Officer | ||
| The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal | |
| Max Planck Institute of Neurobiology | College/University | Doctorate Degree | |
SPARTA AG (Investment Company)
 SPARTA AG (Investment Company) Investment Banks/BrokersFinance Sparta AG (Investment Company) (Sparta-IC) is the investment management division of Sparta AG (FRA: SPT6), an investment company headquartered in Heidelberg, Germany. The firm was founded in 1995 and engages in the acquisition, management, and sale of shareholdings in corporations, partnerships, and listed public companies. Sparta-IC specializes in investments in listed companies on the German and Swiss stock exchanges, primarily from the German-speaking countries. | Investment Banks/Brokers | Chief Executive Officer | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member | |
Mecuris GmbH
 Mecuris GmbH Commercial Printing/FormsCommercial Services Mecuris GmbH operates a software platform for automatic generation of patient-customized orthoses and prosthetic designs. The company was founded by Manuel Opitz, Wolf-Peter Werner, Felix Gundlack, Jannis Breuninger and Simon Weidert and is headquartered in Munich, Germany. | Commercial Printing/Forms | Director/Board Member | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Falkenstein Management GmbH | Founder | ||
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| elho AG | Chairman | ||
SciRhom GmbH
 SciRhom GmbH Miscellaneous Commercial ServicesCommercial Services SciRhom GmbH engages in the development of treatment for life-threatening diseases. The company was founded by Andreas Jenne, Jens Ruhein, Axel Ullrich, Carl Blobel and Matthias Schneider in 2016 and is headquartered in Planegg, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
| Kreissl-Stiftung | Investment Trusts/Mutual Funds | Director/Board Member | |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor Consultant / Advisor |
Statistieken
Internationaal
| Duitsland | 30 |
| Verenigde Staten | 14 |
| Verenigd Koninkrijk | 5 |
| Australië | 2 |
| Denemarken | 2 |
Sectoraal
| Health Technology | 21 |
| Finance | 12 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Miscellaneous | 3 |
Operationeel
| Director/Board Member | 128 |
| Corporate Officer/Principal | 58 |
| Chief Executive Officer | 46 |
| Chairman | 35 |
| Founder | 23 |
Sterkste connecties
| Insiders | |
|---|---|
| Heiko Roman Michael Fischer | 30 |
| Gerald Heinz Möller | 29 |
| Steven St. Peter | 26 |
| Anthony Adam Rosenberg | 23 |
| Henrijette Richter | 21 |
| Patrick Baeuerle | 19 |
| Philip Grosse | 18 |
| Marco Brockhaus | 15 |
| Rainer Strohmenger | 14 |
| Matthias Kromayer | 14 |
| Daniel Vitt | 13 |
| Martin Simon | 13 |
| Christoph Schäfers | 12 |
| Michael Burgess | 12 |
| Rainer Kramer | 10 |
- Beurs
- Insiders
- Apollon Papadimitriou
- Bedrijfsconnecties
